Abuse of psychopharmacological drugs  experiences in Norway.
D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001463:Barbiturates / Q000009:adverse effects; D001569:Benzodiazepines; D006213:Hallucinogens / Q000009:adverse effects; D006801:Humans; D008094:Lithium / Q000009:adverse effects; D008508:Medication Errors; D008620:Meprobamate / Q000009:adverse effects; D009664:Norway; D011619:Psychotropic Drugs / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000209:etiology
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D001463:Barbiturates; D006213:Hallucinogens; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D008094:Lithium; D008620:Meprobamate